Drug to treat breast cancer may help prevent it

Doctors and patients have a new way to prevent breast cancer - a drug already approved, will appear in women who have had to keep it.

A new study has reduced the risk of hormone inhibitors Aromasin invasive breast cancer by 65 percent in postmenopausal women at high risk of breast cancer. Aromasin is also fewer side effects than other drugs to prevent disease.

Researchers recruited 4560 healthy postmenopausal women at high risk of breast cancer in a controlled clinical trial versus placebo.

In absolute terms, need 94 women treated for 3 years to prevent one case of breast cancer.

Aromasin is a class of drugs called aromatase inhibitors currently used to facilitate the return of breast cancer among women in recovery from the disease.

Many studies have shown that estrogen stimulates breast cancer produced by the body. In short, this drug acts as an anti-estrogen. "

What makes a woman at high risk for breast cancer?

"In this study, and more generally," Ashton added: "If there is a high risk of breast cancer, age is the most important factor in the 60 women in this study were postmenopausal women, aromatase has agreed to .... first drug to prevent breast cancer Aromasin does not seem to have these side effects and perhaps acceptable, but the side effects can still Wragge Ashton said: "quite disturbing. It is important, Ashton stressed that women speak with their doctor the risks and benefits to understand in order to avoid these drugs of developing breast cancer.